Mounjaro

Mounjaro (tirzepatide) shows neuroprotective effects in early studies — reducing inflammation, improving vascular health, and supporting cognitive

Mounjaro shows promising early evidence for reducing alcohol cravings through GLP-1 receptor mechanisms, though it’s not FDA-approved for alcohol use

The Mounjaro shortage affects prescription availability nationwide. Learn how to secure tirzepatide, understand FDA shortage status, and explore

Mounjaro rebound hunger occurs when GLP-1 receptor downregulation and ghrelin rebound amplify appetite after dose changes or discontinuation. Here’s the

Mounjaro requires a 2-month washout before conception due to its 5-day half-life. Here’s the timeline, mechanisms, and what fertility specialists

The FDA crackdown on Mounjaro compounding ended legal access to low-cost tirzepatide in late 2024 — here’s what changed and what options remain.

Compounded Mounjaro (tirzepatide) costs 60–85% less than brand-name versions and is legally available during FDA-confirmed shortages through 503B

Mounjaro can alter menstrual cycles through hormonal shifts tied to weight loss and insulin sensitivity changes. Here’s what clinical data shows.

Mounjaro (tirzepatide) can support weight loss during perimenopause by addressing insulin resistance and metabolic shifts — here’s what works and what